Clinical trial
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
NCT01789047 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
- Lead sponsor
- Rush University Medical Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2013
- Completion date
- July 31, 2016
- Enrollment
- 42 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
drug induced dyskinesia, idiopathic parkinson's disease